Mesoblast Ltd has released a press release.
Mesoblast Cells Show Disease Modifying Effects on Knee OA
Filed with ASX ·
Watch Mesoblast's latest callMesoblast (ASX:MSB) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mesoblast (ASX:MSB) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Mesoblast
- MSB partner jcr files for product approval
- Market Exclusivity Strengthened by New USA Healthcare Act
- Key Bone Repair Patent Granted in the United States
- TGA Approval To Commercially Manufacture Stem Cell Products
- Response to an ASX Price Query
Later from Mesoblast
- Mesoblast Provides Q3 Financial Results and Corporate Update
- Mesoblast Receives $6.2m From Aus Govt For R&D
- Suspension from Official Quotation
- Update on Global Heart Failure Program
- Update on Heart Failure Trial and Funding of Operations
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast